Retraction
The role of ATG-7 contributes to pulmonary hypertension by impacting vascular remodeling
Paper Information
Record ID:
34890
Journal:
Publication Date:
April 02, 2021
Retraction Date:
December 29, 2021
(3.9 years years ago)
Subjects:
Institutions:
- Department of Cardiac Surgery, Fujian Medical University Union Hospital, Fuzhou, China
- School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China
- Department of Toxicology, Fujian Center for Evaluation of New Drug, Fujian Medical University, Fuzhou, China
- The Key Laboratory of Fujian Province University on Ion Channel and Signal Transduction in Cardiovascular Disease, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (2)
2
Total Citations0
Post-Retraction1
Pre-Retraction0
Same DayHeavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
PTEN as a Therapeutic Target in Pulmonary Hypertension Secondary to Left-heart Failure: Effect of HO-3867 and Supplemental Oxygenation
Y. Ravi, C.B. Sai-Sudhakar, Periannan Kuppusamy
Cell Biochemistry and Biophysics
Published: Jun 2021
2 citations
2 citations
196 days before retraction
Quick Stats
Total Citations:
2
Years Since Retraction:
3.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025